Coya Therapeutics, Inc.

Public

Coya Therapeutics, Inc. is now publicly traded

The data on this page reflects Coya Therapeutics, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Jan 30, 2026

Total Funding Raised

$11.1M

Company Overview

Coya Therapeutics, Inc. is a biotechnology company developing proprietary treatments focused on the biology and potential therapeutic advantages of regulatory T cells (“Tregs”) to target systemic inflammation and neuroinflammation.

AI Layer

Non-AI

Keywords

regulatory T cellsTreg therapyneurodegenerative disease therapyALS therapycombination therapylow-dose interleukin-2LD IL-2CTLA-4 Igneuro-inflammationbiologicscell therapyexosome therapyautologous Treg cell therapyclinical-stage biotechAlzheimer's disease therapyFrontotemporal DementiaFTDlicensing agreements

Coya Therapeutics, Inc. Comparables

Compare Coya Therapeutics, Inc. with similar companies based on industry and business-model similarity.

Coya Therapeutics, Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Coya Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Jan 30, 2026

View all Funding Rounds

Coya Therapeutics, Inc. Investors

Notable investors and investment history

Coya Therapeutics, Inc. investors
Investor	Rounds
Greenlight Capital	Private Placement

View all Investors

Coya Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Coya Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—

Employee Range17

Year Founded2020

Last FundingJan 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?